Generic capillary electrophoresis conditions for chiral assay in early pharmaceutical development.
Generic capillary electrophoresis (CE) conditions have been implemented for chiral separations in early pharmaceutical development. The chiral CE separations of several pharmaceutical samples at different stages of development, i.e., discovery, process chemistry, and investigative new drug application, have been obtained using sulfated beta-cyclodextrin (CD). Several sulfated beta-CDs have been screened to select an appropriate enantioselective agent. The use of a generic CE method allows for a convenient and rapid chiral recognition of different weak bases, with minimal or no method development. CE using sulfated beta-CD for the chiral separation of N-benzoyl methyl piperazine has been validated for linearity, precision, accuracy, limits of detection and quantitation (LOD, LOQ). Although less sensitive than a specific liquid chromatography method using a Chiralpak AD column, the overall performance of the chiral CE method was found comparable. Validation data demonstrate that a LOD of 0.1%, sufficient to fulfill regulatory requirements, is achievable by chiral CE.
Rocheleau
Marie-Josée
MJ
Pharmaceutical Research Institute Bristol-Myers Squibb, Candiac, Québec, Canada. marie.rocheleau@bms.com
D004345:Drug Industry; D019075:Electrophoresis, Capillary / Q000379:methods*; D005984:Glutethimide / Q000302:isolation & purification; D010879:Piperazines / Q000302:isolation & purification; D013237:Stereoisomerism; D013463:Sulfuric Acid Esters; D047392:beta-Cyclodextrins
C503743:N-benzoylmethylpiperazine; D010879:Piperazines; D013463:Sulfuric Acid Esters; D047392:beta-Cyclodextrins; D005984:Glutethimide